2005
Myocardial viability assessment by PET: (82)Rb defect washout does not predict the results of metabolic-perfusion mismatch.
Stankewicz MA, Mansour CS, Eisner RL, Churchwell KB, Williams BR, Sigman SR, Streeter J, Patterson RE. Myocardial viability assessment by PET: (82)Rb defect washout does not predict the results of metabolic-perfusion mismatch. Journal Of Nuclear Medicine 2005, 46: 1602-9. PMID: 16204709.Peer-Reviewed Original ResearchConceptsMyocardial viabilityLeft ventriclePresence of severityEvidence of viabilityMyocardial viability assessmentNegative predictive valueViable myocardial tissueSurgical revascularizationCoronary diseaseClinical indicationsMetabolic assessmentSeverity criteriaAssessment of viabilityPET imagesPredictive valueWashout criteriaPatientsFDGQuantitative severityMyocardial tissuePositive criteriaGold standardWashoutSmall restingSeverity
2001
Technetium-99m-labeled Myocardial Perfusion Agents: Are They Better than Thallium-201?
Kailasnath P, Sinusas A. Technetium-99m-labeled Myocardial Perfusion Agents: Are They Better than Thallium-201? Cardiology In Review 2001, 9: 160-172. PMID: 11304401, DOI: 10.1097/00045415-200105000-00009.Peer-Reviewed Original ResearchConceptsCoronary artery diseasePerfusion tracerPerfusion agentArtery diseaseMyocardial viabilityThallium-201Perfusion imagingMyocardial perfusion imagingRegional flow heterogeneityPharmacologic stressorChest painMyocardial perfusion agentRisk stratificationAcute assessmentNew perfusion agentTechnetium-99mClinical valueMyocardial uptakeIschemic regionAssessment of viabilityCoronary vasculatureMyocardial flowClearance kineticsMyocardial retentionTracer availability
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply